A detailed history of Ci Private Wealth, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Ci Private Wealth, LLC holds 36,630 shares of ADMA stock, worth $697,435. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,630
Previous 32,339 13.27%
Holding current value
$697,435
Previous $361,000 102.77%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$11.21 - $20.03 $48,102 - $85,948
4,291 Added 13.27%
36,630 $732,000
Q2 2024

Aug 13, 2024

BUY
$5.98 - $11.18 $9,209 - $17,217
1,540 Added 5.0%
32,339 $361,000
Q1 2024

May 09, 2024

BUY
$4.4 - $6.74 $57 - $87
13 Added 0.04%
30,799 $203,000
Q2 2023

Aug 10, 2023

BUY
$3.12 - $4.22 $41,474 - $56,096
13,293 Added 75.99%
30,786 $113,000
Q4 2022

Feb 15, 2023

BUY
$2.47 - $3.88 $43,207 - $67,872
17,493 New
17,493 $67,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.74B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Ci Private Wealth, LLC Portfolio

Follow Ci Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ci Private Wealth, LLC with notifications on news.